This study is looking at how well a Tandem Automated Insulin Delivery (AID) System works for young people newly diagnosed with Type 1 Diabetes. The AID system combines a continuous glucose monitor (which tracks blood sugar), an insulin pump, and a special program to automatically adjust insulin delivery. Participants will start using this system within 2-4 weeks of their diagnosis and use a simple way to announce meals for insulin dosing. The main goal is to see how many participants start using the AID system within two weeks. You might be able to join if you are between 2 and 26 years old, have been diagnosed with Type 1 Diabetes in the last two weeks, and plan to receive care at Stanford Children's Pediatric Diabetes Clinic. This study plans to enroll 16 participants, but its current recruitment status is unclear.

Study design

This is an interventional study with a planned enrollment of 16 participants. It is not specified if it is randomized or blinded.

What's involved

Participants will be required to initiate the AID system within 2-4 weeks of diabetes diagnosis and use a simplified meal announcement strategy for insulin dosing. Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint is measured at 2 weeks, focusing on the number of participants who started the AID system within that timeframe.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.